Overview:
Allergy immunotherapy is a treatment used for preventing allergic reactions that occur due to substances such as bee venom, house dust mites and grass pollens. In this treatment, the dose of the drug which causes allergy to the patient is increased gradually. It reduces inflammation characterizing asthma and rhinitis. The most common type of treatment used in immunotherapy is allergy shots which changes the immune system and helps to prevent development of asthma and new allergies.
The Europe and Japan allergy immunotherapy market is estimated to be valued at US$ 1,228.37 Mn by 2030, and is expected to exhibit a CAGR of 8.1% over the forecast period (2022-2030).
Request a Sample Copy of the Research Report :
https://www.coherentmarketinsights.com/insight/request-sample/5037
Market Drivers:
Key market players are focusing on R&D activities to develop allergy immunotherapy, which is expected to augment growth of the Europe and Japan allergy immunotherapy market during the forecast period. For instance, Regeneron Pharmaceuticals, Inc., in 2021, revealed results of its Phase II proof-of-concept trial that evaluated the investigational antibody cocktail REGN 1908-1909 in patients with mild asthma and allergy to cats.
Moreover, players in the market are adopting various inorganic growth strategies such as agreements for increasing funding for R&D activities ad product pipeline development and this in turn is likely to boost growth of the Europe and Japan allergy immunotherapy market during the forecast period. For instance, Aimmune Therapeutics, Inc. signed an agreement with an affiliate of KKR in 2019 for nearly US$ 170 million to fund the commercialization of an investigational immunotherapy treatment for peanut allergy.
Furthermore, market competitors are also focusing on collaborations to strengthen their service portfolio, which is anticipated to fuel growth of the Europe and Japan allergy immunotherapy market during the forecast period. For instance, in 2020, a biopharmaceutical company, Stallergenes Greer collaborated with a contract research organization, Alyatec for advancement of precision medicine in allergen immunotherapy. (AIT).
Impact of COVID-19:
The pandemic of COVID-19 adversely impacted growth of the Europe and Japan allergy immunotherapy market. Many countries imposed stringent lockdown regulations after the virus outbreak, which disrupted global economy. As per the data of the World Health Organization, the number of cases reported in Japan was 8,718,807 till May 25 and 1,119,084 in Europe in May 22. Various industrial operations were disrupted during the pandemic. The use of allergic immunotherapy declined during this period in patients, due to which the market was negatively impacted.
Request PDF Brochure with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-pdf/5037
Key Takeaways:
Europe and Japan allergy immunotherapy market is estimated to show a CAGR of 8.1% during the forecast period, this is due to rise in potential markets in European region.
Players in the market are focusing on R&D activities to develop immunotherapy drugs for allergy, which is likely to boost growth of the Europe and Japan allergy immunotherapy market over the forecast period. For instance, Allergy Therapeutics Plc. began screening of first patient in the clinical trial that studied efficiency and safety of the Grass MATA MPK in patietns with seasonal rhinoconjunctivitis or allergic rhinitis caused due to grass pollen exposure, in October 2020.
Key Players:
Key players active in the Europe and Japan allergy immunotherapy market are DESENTUM OY, Novartis International AG, Torii Pharmaceutical Co., Ltd., Merck & Co., Inc., Allergy Therapeutics Plc, Aimmune Therapeutics, Inc., ALK-Abelló A/S, Regeneron Pharmaceuticals, Inc., Stallergenes Greer, and HAL Allergy B.V.
Purchase This Complete Business Research Report:
https://www.coherentmarketinsights.com/insight/buy-now/5037
Note: Special discounted pricing is only applicable for direct purchase through website. In case of customization, discount would be subject to scope and coverage of the report.
Explore Detail TOC of the Europe and Japan Allergy Immunotherapy Market Report:
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Treatment
- Market Snippet, By Allergy Type
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Regulatory Scenario
- PEST Analysis
- Recent Product Launch/Approval
- Epidemiology
- Mergers and Acquisitions
- Market Dynamics
- Europe and Japan Allergy Immunotherapy Market – Impact of Coronavirus (Covid-19) Pandemic
- Impact on Supply Chain
- Impact on Research and Development
- Government Initiatives
- Europe and Japan Allergy Immunotherapy Market, By Treatment, 2017-2030 (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 – 2030
- Segment Trends
- Subcutaneous Immunotherapy (SCIT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Million)
- Sublingual Immunotherapy (SLIT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Million)
- Introduction
- Europe and Japan Allergy Immunotherapy Market, By Allergy Type, 2017 – 2030 (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 – 2030
- Segment Trends
- Allergy Rhinitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Million)
- Allergy Asthma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Million)
- Pollen Allergies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Million)
- Cedar
- Birch
- Oak
- Others
- Pet Allergy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Million)
- Cats
- Dogs
- Other Pets
- Birds Allergy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Million)
- Introduction
- Europe and Japan Allergy Immunotherapy Market, By Distribution Channel, 2017 – 2030 (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 – 2030
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Million)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Million)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Million)
- Introduction
- Europe and Japan Allergy Immunotherapy Market, By Region, 2017 – 2030 (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2018 – 2030
- Regional Trends
- Europe
- Market Size and Forecast, By Treatment, 2017 – 2030 (US$ Mn)
- Market Size and Forecast, By Allergy Type, 2017 – 2030 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 – 2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2030 (US$ Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Denmark
- Sweden
- Poland
- Belgium
- Netherlands
- Russia
- Rest of Europe
- Japan
- Market Size and Forecast, By Treatment, 2017 – 2030 (US$ Mn)
- Market Size and Forecast, By Allergy Type, 2017 – 2030 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 – 2030 (US$ Mn)
- Introduction
- Competitive Landscape
- Company Profiles
- Novartis International AG
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Merck & Co., Inc.
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Aimmune Therapeutics, Inc.
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Regeneron Pharmaceuticals, Inc.
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- HAL Allergy B.V.
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Stallergenes Greer
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- ALK-Abelló A/S
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Allergy Therapeutics Plc
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Torii Pharmaceutical Co., Ltd.
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- DESENTUM OY
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Novartis International AG
- Analyst Views
- Company Profiles
- Section
- References
- Research Methodology
- About us and Sales Contact
About Us
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact us:
Mr. Shah
Coherent Market Insights
533 Airport Boulevard, Suite 400,
Burlingame, CA 94010, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com